BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 26842712)

  • 21. Expression of NUCB2/nesfatin-1 in the taste buds of rats.
    Cao X; Zhou X; Cao Y; Liu XM; Zhou LH
    Endocr J; 2016; 63(1):37-45. PubMed ID: 26522144
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibin-α subunit expression in uterine endometrioid adenocarcinomas and endometrial cancer cell lines: a potential prognostic factor.
    Mylonas I
    Int J Mol Med; 2011 Mar; 27(3):309-18. PubMed ID: 21174065
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression and the clinical significance of Wnt10a and Wnt10b in endometrial cancer are associated with the Wnt/β-catenin pathway.
    Chen H; Wang Y; Xue F
    Oncol Rep; 2013 Feb; 29(2):507-14. PubMed ID: 23135473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progesterone and 17β-estradiol regulate expression of nesfatin-1/NUCB2 in mouse pituitary gland.
    Chung Y; Kim J; Im E; Kim H; Yang H
    Peptides; 2015 Jan; 63():4-9. PubMed ID: 25451467
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Developmental expression and distribution of nesfatin-1/NUCB2 in the canine digestive system.
    Jiang S; Zhou W; Zhang X; Wang D; Zhu H; Hong M; Gong Y; Ye J; Fang F
    Acta Histochem; 2016 Mar; 118(2):90-6. PubMed ID: 26643216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. STAR and AKR1B10 are down-regulated in high-grade endometrial cancer.
    Sinreih M; Štupar S; Čemažar L; Verdenik I; Frković Grazio S; Smrkolj Š; Rižner TL
    J Steroid Biochem Mol Biol; 2017 Jul; 171():43-53. PubMed ID: 28232277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulinotropic nucleobindin-2/nesfatin-1 is dynamically expressed in the haemochorial mouse and human placenta.
    Legg-St Pierre CB; Mackova M; Miskiewicz EI; Hemmings DG; Unniappan S; MacPhee DJ
    Reprod Fertil Dev; 2018 Mar; 30(3):519-532. PubMed ID: 28855042
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification and characterization of nesfatin-1 immunoreactivity in endocrine cell types of the rat gastric oxyntic mucosa.
    Stengel A; Goebel M; Yakubov I; Wang L; Witcher D; Coskun T; Taché Y; Sachs G; Lambrecht NW
    Endocrinology; 2009 Jan; 150(1):232-8. PubMed ID: 18818289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of mutations in the NUCB2/nesfatin gene in children with severe obesity.
    Zegers D; Beckers S; de Freitas F; Jennes K; Van Camp JK; Mertens IL; Van Hoorenbeeck K; Rooman RP; Desager KN; Massa G; Van Gaal LF; Van Hul W
    Mol Genet Metab; 2012 Dec; 107(4):729-34. PubMed ID: 23141462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical significance of Sam68 expression in endometrial carcinoma.
    Wang Q; Li Y; Zhou J; Liu J; Qin J; Xing F; Zhang J; Cheng J
    Tumour Biol; 2015 Jun; 36(6):4509-18. PubMed ID: 25874492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of nesfatin-1 on food intake and LH secretion in prepubertal gilts and genomic association of the porcine NUCB2 gene with growth traits.
    Lents CA; Barb CR; Hausman GJ; Nonneman D; Heidorn NL; Cisse RS; Azain MJ
    Domest Anim Endocrinol; 2013 Aug; 45(2):89-97. PubMed ID: 23820242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The E-Cadherin expression vs. tumor cell proliferation paradox in endometrial cancer.
    González-Rodilla I; Aller L; Llorca J; Muñoz AB; Verna V; Estévez J; Schneider J
    Anticancer Res; 2013 Nov; 33(11):5091-5. PubMed ID: 24222154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progesterone receptor negativity is an independent risk factor for relapse in patients with early stage endometrioid endometrial adenocarcinoma.
    Huvila J; Talve L; Carpén O; Edqvist PH; Pontén F; Grénman S; Auranen A
    Gynecol Oncol; 2013 Sep; 130(3):463-9. PubMed ID: 23777659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expanding roles of NUCB2/nesfatin-1 in neuroendocrine regulation.
    García-Galiano D; Navarro VM; Gaytan F; Tena-Sempere M
    J Mol Endocrinol; 2010 Nov; 45(5):281-90. PubMed ID: 20682642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical detection of histone deacetylases in endometrial carcinoma: involvement of histone deacetylase 2 in the proliferation of endometrial carcinoma cells.
    Fakhry H; Miyamoto T; Kashima H; Suzuki A; Ke H; Konishi I; Shiozawa T
    Hum Pathol; 2010 Jun; 41(6):848-58. PubMed ID: 20178884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of NUCB2/nesfatin-1 production in rat's stomach and adipose tissue is dependent on age, testosterone levels and lactating status.
    Senin LL; Al-Massadi O; Barja-Fernandez S; Folgueira C; Castelao C; Tovar SA; Leis R; Lago F; Baltar J; Baamonde I; Dieguez C; Casanueva FF; Seoane LM
    Mol Cell Endocrinol; 2015 Aug; 411():105-12. PubMed ID: 25916958
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nesfatin-1 suppresses energy intake, co-localises ghrelin in the brain and gut, and alters ghrelin, cholecystokinin and orexin mRNA expression in goldfish.
    Kerbel B; Unniappan S
    J Neuroendocrinol; 2012 Feb; 24(2):366-77. PubMed ID: 22023656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Troglitazone, a ligand of peroxisome proliferator-activated receptor-{gamma}, stabilizes NUCB2 (Nesfatin) mRNA by activating the ERK1/2 pathway: isolation and characterization of the human NUCB2 gene.
    Yamada M; Horiguchi K; Umezawa R; Hashimoto K; Satoh T; Ozawa A; Shibusawa N; Monden T; Okada S; Shimizu H; Mori M
    Endocrinology; 2010 Jun; 151(6):2494-503. PubMed ID: 20427483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ghrelin, ghrelin-O-acyl transferase, nucleobindin-2/nesfatin-1 and prohormone convertases in the pancreatic islets of Sprague Dawley rats during development.
    Mohan H; Gasner M; Ramesh N; Unniappan S
    J Mol Histol; 2016 Jun; 47(3):325-36. PubMed ID: 27071923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated expression of RIT1 correlates with poor prognosis in endometrial cancer.
    Xu F; Sun S; Yan S; Guo H; Dai M; Teng Y
    Int J Clin Exp Pathol; 2015; 8(9):10315-24. PubMed ID: 26617739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.